1. Repository of OAI
Ελληνικά   English  

Browsing by Author Roukos, D. H.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 140  next >
TitleAuthor(s)Issue date???itemlist.???
Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery?Roukos, D. H.24-Nov-2015-
Adjuvant chemotherapy in gastric cancerRoukos, D. H.; Paraschou, P.24-Nov-2015-
Advances in locating lymph nodes by endoscopic ultrasound-guided fine-needle markingBaltogiannis, G.; Katsios, C. G.; Roukos, D. H.24-Nov-2015-
Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutationsRoukos, D. H.; Agnanti, N. J.; Paraskevaidis, E.; Kappas, A. M.24-Nov-2015-
Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer preventionRoukos, D. H.24-Nov-2015-
Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancerRoukos, D. H.24-Nov-2015-
'Big' science: genome regulatory networks and novel molecular tools to improve healthRoukos, D. H.24-Nov-2015-
Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?Roukos, D. H.24-Nov-2015-
Biotechnological, genomics and systems-synthetic biology revolution: redesigning genetic code for a pragmatic systems medicineRoukos, D. H.24-Nov-2015-
Breast and gastric cancer: comparing what we learnRoukos, D. H.; Briasoulis, E.; Michos, K. M.; Elisaf, M. S.; Agnantis, N. J.; Kappas, A. M.24-Nov-2015-
Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biologyRoukos, D. H.24-Nov-2015-
Breast-cancer stromal cells with TP53 mutationsRoukos, D. H.24-Nov-2015-
Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer?Roukos, D. H.; Liakakos, T.; Karatzas, G.; Kappas, A. M.24-Nov-2015-
Cancer genome explosion and systems biology: impact on surgical oncology?Roukos, D. H.24-Nov-2015-
Cancer genome sequencing and functional genomics: from translational to clinical medicineRoukos, D. H.24-Nov-2015-
Cancer genome sequencing and potential application in oncologyKatsios, C.; Zoras, O.; Roukos, D. H.24-Nov-2015-
CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer?Ziogas, D.; Roukos, D. H.24-Nov-2015-
Challenges in developing robust genetic markers and targets to predict and prevent distant and peritoneal recurrence in gastric cancerZiogas, D.; Roukos, D. H.24-Nov-2015-
Chromatin: a key player in complex gene regulation and future cancer therapeuticsRoukos, D. H.24-Nov-2015-
Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?Hanisch, E.; Hottenrott, C.; Roukos, D. H.24-Nov-2015-
Showing results 1 to 20 of 140  next >